Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Total Non-Current Liabilities (2021 - 2026)

Core Scientific has reported Total Non-Current Liabilities over the past 6 years, most recently at $4.3 billion for Q1 2026.

  • Quarterly results put Total Non-Current Liabilities at $4.3 billion for Q1 2026, up 138.03% from a year ago — trailing twelve months through Mar 2026 was $4.3 billion (up 138.03% YoY), and the annual figure for FY2025 was $3.2 billion, up 142.57%.
  • Total Non-Current Liabilities reached $4.3 billion in Q1 2026 per CORZ's latest filing, up from $3.2 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $4.3 billion in Q1 2026 and bottomed at $206.7 million in Q1 2023.
  • Median Total Non-Current Liabilities over the past 5 years was $1.3 billion (2024), compared with a mean of $1.7 billion.
  • The largest annual shift saw Total Non-Current Liabilities soared 11709.1% in 2022 before it crashed 86.43% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $1.2 billion in 2022, then grew by 7.76% to $1.3 billion in 2023, then increased by 0.96% to $1.3 billion in 2024, then surged by 142.57% to $3.2 billion in 2025, then soared by 33.33% to $4.3 billion in 2026.
  • Business Quant data shows Total Non-Current Liabilities for CORZ at $4.3 billion in Q1 2026, $3.2 billion in Q4 2025, and $2.1 billion in Q3 2025.